
[Federal Register Volume 79, Number 174 (Tuesday, September 9, 2014)]
[Notices]
[Page 53430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21369]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0001]


Advisory Committee Renewals; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
entitled ``Advisory Committee Renewals'' that appeared in the Federal 
Register of August 25, 2014 (79 FR 50658). The document announced the 
renewal of certain FDA advisory committees by the Commissioner of Food 
and Drugs. The table in the document contained several errors. This 
document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3330, 
Silver Spring, MD 20993-0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of Monday, August 
25, 2014, in FR Doc. 2014-20017, on page 50659 the table is corrected 
to read:

------------------------------------------------------------------------
          Name of committee                   Date of expiration
------------------------------------------------------------------------
Advisory Committee for                January 22, 2016.
 Pharmaceutical Science and Clinical
 Pharmacology.
Gastrointestinal Drugs Advisory       March 3, 2016.
 Committee.
Bone, Reproductive and Urologic       March 23, 2016.
 Drugs Advisory Committee (formerly
 Reproductive Health Drugs Advisory
 Committee).
Arthritis Advisory Committee........  April 5, 2016.
Pharmacy Compounding Advisory         April 25, 2016.
 Committee.
Anesthetic and Analgesic Drugs        May 1, 2016.
 Advisory Committee.
Blood Products Advisory Committee...  May 13, 2016.
Pulmonary-Allergy Drugs Advisory      May 30, 2016.
 Committee.
Drug Safety and Risk Management       May 31, 2016.
 Advisory Committee.
Science Advisory Board to the         June 2, 2016.
 National Center for Toxicological
 Research.
Peripheral and Central Nervous        June 4, 2016.
 System Drugs Advisory Committee.
Psychopharmacologic Drugs Advisory    June 4, 2016.
 Committee.
Transmissible and Spongiform          June 9, 2016.
 Encephalopathies Advisory Committee.
Science Board to the Food and Drug    June 26, 2016.
 Administration.
Allergenic Products Advisory          July 9, 2016.
 Committee.
------------------------------------------------------------------------


    Dated: September 3, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2014-21369 Filed 9-8-14; 8:45 am]
BILLING CODE 4164-01-P


